Search

Your search keyword '"Liu Wei-Ping"' showing total 869 results

Search Constraints

Start Over You searched for: Author "Liu Wei-Ping" Remove constraint Author: "Liu Wei-Ping"
869 results on '"Liu Wei-Ping"'

Search Results

1. Fast GC-SPI-TOF MS for On-board Monitoring of Volatile Organic Compounds in Air

2. Infrared heating system based on automated fiber placement for thermoplastic composites

3. An indirect technique in nuclear astrophysics: alpha-cluster transfer reaction

4. Direct measurement of the break-out 19F(p, γ)20Ne reaction in the China Jinping underground laboratory (CJPL)

7. Stepped-up development of accelerator mass spectrometry method for the detection of 60Fe with the HI-13 tandem accelerator

9. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

10. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

25. Sporadic Burkitt lymphomas of children and adolescents in Chinese: a clinicopathological study of 43 cases

26. Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases

27. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution

28. Health-related quality of life in glioma patients in China

29. Correction to: The chemodiversity of paddy soil dissolved organic matter correlates with microbial community at continental scales

34. The nature of the Li enrichment in the most Li-rich giant star

35. New determination of the spectroscopic factor of $^7$Be ground state and the $^6$Li($p,\gamma$)$^7$Be astrophysical S(E) factors

36. The chemodiversity of paddy soil dissolved organic matter correlates with microbial community at continental scales

41. Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol

42. Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

45. Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.

46. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study

47. Intensive therapy can improve long‐term survival in newly diagnosed, advanced‐stage extranodal NK/T‐cell lymphoma: A multi‐institutional, real‐world study

Catalog

Books, media, physical & digital resources